Entera Bio Ltd. (ENTX): Prakiraan gabungan firma investasi

This chart of Entera Bio Ltd. (ENTX) stock quotes demonstrates the dynamics of a company whose current metric value is 9.99. Despite geopolitical turbulence in Israel, the humanitarian profile of the business offsets sanction threats. The enterprise is creating an oral protein delivery system, replacing osteoporosis injections with convenient tablets. The development of non-refrigerated drug transport methods optimizes costs and strengthens supply chain profitability.

ENTX - Target konsensus Entera Bio Corp ing rentang 04.07.2022 - 22.10.2026

Rincian analitis perusahaan Entera Bio Ltd. (ENTX)

ENTX — sistem indikator bursa lan keuangan enterabio.com:

Rega bursa enterabio.com|ENTX - Bagan rega target|Kapitalisasi pasar Entera Bio Corp

Analisis umum perusahaan:ENTX Entera Bio Ltd

Barang unggulan Entera Bio

The operational resilience of Entera Bio Ltd. (ENTX) amid Israeli geopolitical risks directly impacts the estimated business value that analysts aggregate into a single target price. This metric, available on GURU.Markets, reflects the average capitalization valuation adjusted for industry specifics, allowing investors to determine the asset's degree of undervaluation against a backdrop of market turbulence via the investment community's average benchmark.

Pesaing Entera Bio Ltd.

HLN - Rata-rata rega prakiraan|Bagan rega target Kenvue KVUE|VRNA: Prakiraan gabungan firma investasi|MENS: Target konsensus|Ligand Corp - Rega prakiraan analis|AMRX (Amneal Pharmaceuticals) - Target konsensus|Prakiraan gabungan firma investasi PRGO|Bagan rega target Alvotech SA|Liquidia Corp - Bagan tingkat prakiraan|Prakiraan konsensus analis GLPG|ANIP (ANI Pharmaceuticals Corp) - Konsensus nilai wajar|Prakiraan konsensus analis MNKD (MannKind Corporation)|Prakiraan konsensus analis amphastar.com AMPH|PCRX - Bagan rega target|Konsensus nilai wajar SPRY (ARS Pharmaceuticals Inc)|Theravance (TBPH) - Bagan rega target|Target konsensus Aquestive Corp|SCPH (scPharmaceuticals, Inc.) - Prakiraan konsensus analis|Prakiraan konsensus analis Tectonic|Target konsensus TNXP (Tonix Pharmaceuticals Holding Corp.)|SXTC (sxtchina.com) - Konsensus nilai wajar|Bagan rega target Eupraxia Pharmaceuticals Inc. EPRX|BioHarvest Sciences Inc (BHST) - Rata-rata rega prakiraan|EXOZ: Target konsensus|Oramed Pharmaceuticals - Rega prakiraan analis|HYFT: Prakiraan konsensus analis|ABVC BioPharma Inc. - Konsensus nilai wajar|CPIX (Cumberland Pharma) - Prakiraan konsensus analis|Rata-rata rega prakiraan Quantum BioPharma Corp QNTM|Bagan rega target FibroGen, Inc. (FGEN)|TELO (telomirpharma.com) - Konsensus nilai wajar|Prakiraan konsensus analis RANI (Rani Therapeutics Holdings, Inc.)|Synergy CHC Corp. (SNYR) - Rata-rata rega prakiraan|RLYB - Bagan rega target|LEXX (Lexaria Bioscience) - Prakiraan gabungan firma investasi|PULM (Pulmatrix, Inc.) - Target konsensus|PTHL: Rega prakiraan analis|APM (Aptorum Group Ltd) - Prakiraan konsensus analis|Rata-rata rega prakiraan Lyra Therapeutics Inc. LYRA|Bagan rega target Impact BioMedical Inc (IBO)|TNFA (tnfpharma.com) - Konsensus nilai wajar|Prakiraan konsensus analis YCBD (cbdMD)|Prakiraan konsensus analis painreform.com PRFX|CYTO: Target konsensus|Konsensus nilai wajar LIPO (Lipella Pharmaceuticals Inc)|OPTN: Prakiraan konsensus analis|PIRS (Pieris Pharma) - Bagan rega target|PROC (Procaps Group S.A.) - Prakiraan konsensus analis|petrospharma.com (PTPI) - Target median analis|Bagan rega target Qilian International Holding (QLI)|SLRN - Rata-rata rega prakiraan|TFF Pharma - Target konsensus